Hey, does anyone remember that randomised, doubleblind trial with a couple of hundred Covid ARDS patients, where half of them got doses of Remestemcel to match the dosing used with GVHD?
Wonder if they had any assay data from that trial that they were able to share with FDA in relation to the GVHD application.
Just thinking out loud.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1007
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.000(0.00%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $4.912M | 3.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 16401 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 8722 | 7 |
View Market Depth
| Last trade - 14.34pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |